126 related articles for article (PubMed ID: 15991281)
1. Expression and significance of tumor-related genes in HCC.
Lü ZL; Luo DZ; Wen JM
World J Gastroenterol; 2005 Jul; 11(25):3850-4. PubMed ID: 15991281
[TBL] [Abstract][Full Text] [Related]
2. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of genes associated with human hepatocellular carcinogenesis.
Kondoh N; Wakatsuki T; Ryo A; Hada A; Aihara T; Horiuchi S; Goseki N; Matsubara O; Takenaka K; Shichita M; Tanaka K; Shuda M; Yamamoto M
Cancer Res; 1999 Oct; 59(19):4990-6. PubMed ID: 10519413
[TBL] [Abstract][Full Text] [Related]
4. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Twist gene in human hepatocellular carcinoma and its clinicopathological significance].
Li CH; Chen XP; Xu ZQ; Li GP; Guan J
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1353-6. PubMed ID: 17217825
[TBL] [Abstract][Full Text] [Related]
7. Expression of cancer-testis antigens in hepatocellular carcinoma.
Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY
World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429
[TBL] [Abstract][Full Text] [Related]
8. Glypican-3 is overexpressed in human hepatocellular carcinoma.
Sung YK; Hwang SY; Park MK; Farooq M; Han IS; Bae HI; Kim JC; Kim M
Cancer Sci; 2003 Mar; 94(3):259-62. PubMed ID: 12824919
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153
[TBL] [Abstract][Full Text] [Related]
10. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.
Qian J; Yao D; Dong Z; Wu W; Qiu L; Yao N; Li S; Bian Y; Wang Z; Shi G
Am J Clin Pathol; 2010 Nov; 134(5):799-806. PubMed ID: 20959664
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
13. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
14. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
15. [Expression of two types of melanoma antigens in hepatocellular carcinoma].
Cai S; Leng X; Wang Y
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):205-7. PubMed ID: 11783086
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
17. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
Shen HW; Wu YL; Peng SY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
[TBL] [Abstract][Full Text] [Related]
18. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
[TBL] [Abstract][Full Text] [Related]
19. [A study of gene amplification and expression of cyclin D1 in hepatocellular carcinoma].
Xu JM; Wen JM; Zhang M; Lü GL; Wu LZ; Wang WS
Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):26-30. PubMed ID: 14989924
[TBL] [Abstract][Full Text] [Related]
20. Glypican-3 and Melanoma Antigen Genes 1 and 3 as Tumor Markers for Hepatocellular Carcinoma.
El-Wahab NM; Rashed HG; El-Sherif WT; Sayed SK; Abd-Elmalek MO; Refaiy A; Fakhry H; Mokhtar AA
Egypt J Immunol; 2017 Jun; 24(2):187-200. PubMed ID: 29708315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
